Anzeige
Mehr »
Login
Dienstag, 07.05.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
+56,25% in 5 Tagen: Genialer Schachzug - diese Übernahme verändert alles
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
18 Leser
Artikel bewerten:
(0)

Global DNA Sequencing Products Market 2016-2020 - Advances in Personalized Medicine a Key Trend - Research and Markets

DUBLIN, July 5, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Global DNA Sequencing Products Market 2016-2020" report to their offering.

The report forecasts the global DNA sequencing products market to grow at a CAGR of 18.75% during the period 2016-2020.

The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend that is expected to boost market growth in a big way is the advances in personalized medicine. Many medical facilities in developed countries and a few in developing countries are implementing DNA sequencing technologies in medical treatment. These facilities use sophisticated technologies and tools such as rapid DNA sequencer for large-scale and quantitative assessments of genomic sequences. These devices have helped make important research discoveries in the area of biomedical sciences. These research results are implemented in clinical settings, particularly in oncology, for the development of personalized medicine.

According to the report, a key growth driver is the development of rapid sequencing platforms. Further, the report states that one challenge that could hamper market growth is the limitations of DNA sequencing technologies.

Key vendors:

  • Illumina
  • Thermo Fisher Scientific
  • Roche Diagnostics
  • Pacific Biosciences

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Types of sequencing technology platforms

PART 07: Reimbursement and coverage

PART 08: Regulation of next-generation sequencing tests in US

PART 09: Market segmentation by product

PART 10: Market segmentation by end-user

PART 11: Geographical segmentation

PART 12: Market drivers

PART 13: Impact of drivers

PART 14: Market challenges

PART 15: Impact of drivers and challenges

PART 16: Market trends

PART 17: Vendor landscape

PART 18: Appendix

For more information visit http://www.researchandmarkets.com/research/2pfqv6/global_dna

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.